Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Graefe's Archive for Clinical and Experimental Ophthalmology

• Publication date

  2010-05-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00417-010-1379-9PMID 20437247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis.

  2008cited by this paper
• Recurrence characteristics in European patients with ocular toxoplasmosis

  2008cited by this paper
• Active ocular toxoplasmosis in Turkish patients: a report on 109 cases

  2007cited by this paper
• [Ocular toxoplasmosis].

  2007cited by this paper
• Uveitis: A Potentially Blinding Disease

  2004influential reference
• Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review.

  2003cited by this paper
• Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease.

  2003cited by this paper
• Ocular toxoplasmosis: clinical features and prognosis of 154 patients.

  2002cited by this paper
• Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.

  1999influential reference
• Azithromycin for ocular toxoplasmosis

  1998cited by this paper
• Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease.

  1998cited by this paper
• Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis

  1998cited by this paper
• Ocular Infection and Immunity

  1996cited by this paper
• Examination of some factors responsible for a food-induced increase in absorption of atovaquone.

  1994cited by this paper
• Therapy of ocular toxoplasmosis.

  1993cited by this paper
• Soziale Kosten von Sehbehinderung und Blindheit. Rehabilitationsangebot für die Betroffenen

  1992cited by this paper
• [Social costs of visual handicap and blindness. Rehabilitation resources for blind patients].

  1992cited by this paper
• Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii.

  1991cited by this paper
• Therapy of ocular toxoplasmosis

  1989cited by this paper
• Murine model of intracerebral toxoplasmosis.

  1987cited by this paper
• TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY.

  1964cited by this paper
• Toxoplasma chorioretinitis in adults.

  1952cited by this paper

• Considerations in the management of ocular toxoplasmosis in pregnancy: a review of literature

  2024cites this paper
• A screen of drug-like molecules identifies chemically diverse electron transport chain inhibitors in apicomplexan parasites

  2022cites this paper
• Ocular Toxoplasmosis: A Review of Current Literature

  2022cites this paper
• Ocular Toxoplasmosis: An Update on Diagnosis, Multimodal Imaging and Therapy

  2021cites this paper
• Ocular Toxoplasmosis

  2020cites this paper
• Comparison between the areas of scarred and active toxoplasmic retinochoroiditis

  2020cites this paper
• Divergent features of the coenzyme Q:cytochrome c oxidoreductase complex in Toxoplasma gondii parasites

  2020cites this paper
• Ocular disease due to Toxoplasma gondii

  2020cites this paper
• Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis.

  2019cites this paper
• Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites

  2019cites this paper
• Therapeutic approaches to prevent disease recurrence in uveitis

  2019cites this paper
• Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice

  2018cites this paper
• Congenital Toxoplasmosis: Time for a New Treatment Approach

  2017cites this paper
• A Case Series of Retinochoroidal Toxoplasmosis from Western India: Guide to Salient Features, Diagnosis and Treatment

  2016cites this paper
• New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections

  2016cites this paper
• Host and Toxoplasma gondii genetic and non-genetic factors influencing the development of ocular toxoplasmosis: A systematic review.

  2016cites this paper
• Quantitative assessment of the effects of sulfamethoxazole on Toxoplasma gondii loads in susceptible WT C57BL/6 mice as an immunocompetent host model.

  2016cites this paper
• Advances in Ocular Toxoplasmosis

  2016cites this paper
• Antimicrobial Agents for Ocular Use: Bacterial, Fungal, Viral, and Protozoal Infections

  2016cites this paper
• Ocular toxoplasmosis: background and evidence for an antibiotic prophylaxis

  2015cites this paper
• INCREASED RISK OF RECURRENCE AFTER SUFFERING AN ACTIVE LESION OF OCULAR TOXOPLASMOSIS

  2015cites this paper
• Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro.

  2015cites this paper
• Current Treatment of Toxoplasma Retinochoroiditis: An Evidence-Based Review

  2014cites this paper
• Ocular toxoplasmosis in an immunocompetent 8-year-old child: a new active lesion or a late manifestation of a congenital toxoplasmosis?

  2014cites this paper
• Ocular toxoplasmosis past, present and new aspects of an old disease.

  2014cites this paper
• Therapy for Ocular Toxoplasmosis – The Future

  2013cites this paper
• Ocular toxoplasmosis II: clinical features, pathology and management

  2013cites this paper
• Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis

  2012cites this paper
• Inflammatorische choroidale Neovaskularisationen

  2012cites this paper
• New naphthoquinones and an alkaloid with in vitro activity against Toxoplasma gondii RH and EGS strains.

  2012cites this paper
• Azithromycin versus Sulfadiazine and Pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: A pilot study

  2012cites this paper
• Ocular Toxoplasmosis: Advances in Detection and Treatment

  2011cites this paper
• Therapy for Ocular Toxoplasmosis

  2011cites this paper